{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:57:06Z","timestamp":1792637826623,"version":"4.5.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1093\/europace\/eut263","type":"journal-article","created":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T22:47:44Z","timestamp":1380667664000},"page":"6-14","source":"Crossref","is-referenced-by-count":332,"title":["Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events\u2014European Registry in Atrial Fibrillation (PREFER in AF)"],"prefix":"10.1093","volume":"16","author":[{"given":"Paulus","family":"Kirchhof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Ammentorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Darius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Le Heuzey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard John","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,10,1]]},"reference":[{"key":"key\n\t\t\t\t20170522224827_EUT263C1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170522224827_EUT263C2","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170522224827_EUT263C3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/europace\/eur241","article-title":"Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options\u2014a report from the 3rd Atrial Fibrillation Competence NETwork\/European Heart Rhythm Association consensus conference","volume":"14","author":"Kirchhof","year":"2012","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170522224827_EUT263C4","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehs446","article-title":"Atrial fibrillation guidelines across the Atlantic: a comparison of the current recommendations of the European Society of Cardiology\/European Heart Rhythm Association\/European Association Of Cardiothoracic Surgeons, the American College of Cardiology Foundation\/American Heart Association\/Heart Rhythm Society, and the Canadian Cardiovascular Society","author":"Kirchhof","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170522224827_EUT263C5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2458-7-203","article-title":"Implementing hospital guidelines improves warfarin use in non-valvular atrial fibrillation: a before-after study","volume":"7","author":"Bo","year":"2007","journal-title":"BMC Public Health"},{"key":"key\n\t\t\t\t20170522224827_EUT263C6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0002-9149(03)00821-X","article-title":"Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs","volume":"92","author":"Zimetbaum","year":"2003","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170522224827_EUT263C7","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1053\/euhj.2000.2300","article-title":"Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications","volume":"22","author":"Frykman","year":"2001","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170522224827_EUT263C8","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170522224827_EUT263C9","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/europace\/eum191","article-title":"Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association","volume":"9","author":"Kirchhof","year":"2007","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170522224827_EUT263C10","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ahj.2007.03.008","article-title":"Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation","volume":"153","author":"Nieuwlaat","year":"2007","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170522224827_EUT263C11","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1160\/TH11-02-0070","article-title":"Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions","volume":"105","author":"Kirchhof","year":"2011","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20170522224827_EUT263C12","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00392-011-0320-5","article-title":"Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry","volume":"100","author":"Meinertz","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"key\n\t\t\t\t20170522224827_EUT263C13","article-title":"Atrial fibrillation management, outcomes and predictors of stable disease in daily practice: prospective non-interventional study","author":"Bosch","year":"2012","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20170522224827_EUT263C14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.03.034","article-title":"Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on cardiac rhythm disorders assessing the control of atrial fibrillation)","volume":"58","author":"Camm","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170522224827_EUT263C15","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the euro heart survey on atrial fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170522224827_EUT263C16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/europace\/eun369","article-title":"The Registry of the German Competence NETwork on Atrial Fibrillation: Patient characteristics and initial management","volume":"11","author":"Nabauer","year":"2009","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170522224827_EUT263C17","first-page":"794","article-title":"EUR Observational research programme: atrial fibrillation general registry pilot phase","volume":"34","author":"Lip","year":"2013","journal-title":"Eur H J"},{"key":"key\n\t\t\t\t20170522224827_EUT263C18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacc.2009.11.040","article-title":"Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis","volume":"55","author":"de Vos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170522224827_EUT263C19","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/CIRCULATIONAHA.106.644484","article-title":"Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study","volume":"115","author":"Jahangir","year":"2007","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170522224827_EUT263C20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.amjcard.2012.11.026","article-title":"Frequency, patient characteristics, treatment strategies, and resource usage of atrial fibrillation (from the Italian Survey of Atrial Fibrillation Management [ISAF] study)","volume":"111","author":"Zoni-Berisso","year":"2013","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170522224827_EUT263C21","doi-asserted-by":"crossref","first-page":"e63479","DOI":"10.1371\/journal.pone.0063479","article-title":"Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry","volume":"8","author":"Kakkar","year":"2013","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170522224827_EUT263C22","doi-asserted-by":"crossref","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170522224827_EUT263C23","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/16\/1\/6\/17428081\/eut263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T21:48:24Z","timestamp":1503438504000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article-lookup\/doi\/10.1093\/europace\/eut263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,1]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,10,1]]},"published-print":{"date-parts":[[2014,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/eut263","relation":{},"ISSN":["1532-2092","1099-5129"],"issn-type":[{"value":"1532-2092","type":"electronic"},{"value":"1099-5129","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10,1]]}}}